Jie He

68PUBLICATIONS
98CO-AUTHORS
Cancer diagnosisMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Rehabilitation engineeringPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (68)

|Sep 09, 2026
Early stage nonsmall cell lung cancer: Toward a risk-adaptive paradigm in the era of biologic precision.

|Aug 26, 2026
Proteomic landscape of pan-tissue neuroendocrine carcinomas defines subtype-specific functional architectures, biomarkers and therapeutic targets.

|May 04, 2026
Treatment patterns and clinical outcomes of neoadjuvant chemoimmunotherapy for patients with resected oesophageal squamous cell carcinoma: a Chinese multicentre retrospective study.

|Feb 27, 2026
Inhibiting ADAR1-Mediated Excessive Epigenetic A-to-I RNA Editing Improves the Immune Microenvironment and Increases Sensitivity to Immunotherapy in Lung Adenocarcinoma.

Sihui Wang, Sufei Zheng, Chengming Liu

|Feb 12, 2026
Clinical Benefit of PD-1/PD-L1 Inhibitors as Standard First-Line Treatment in Low PD-L1-Expressing Advanced Solid Tumors: A Systematic Review and Meta-Analysis.

Peng Wu, Xuanyu Gu, Dongyu Li

|Oct 24, 2025
Tumor-secreted AGR2 induces dendritic cell dysfunction and impairs immunotherapy efficacy in LKB1-deficient cancer.

Yuxin Yao, Yuejun Luo, Zhanyu Wang

Pageof 12

Frequent Collaborators

5 joint publications

Nan Sun

5 joint publications

Ni Li

4 joint publications

Wei Guo

4 joint publications

Zhenlin Yang